72 related articles for article (PubMed ID: 20002623)
21. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
Paes B; Steele S; Janes M; Pinelli J
Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
[TBL] [Abstract][Full Text] [Related]
22. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management.
Marchisio P; Claut L; Rognoni A; Esposito S; Passali D; Bellussi L; Drago L; Pozzi G; Mannelli S; Schito G; Principi N
Pediatr Infect Dis J; 2003 Mar; 22(3):262-8. PubMed ID: 12634589
[TBL] [Abstract][Full Text] [Related]
23. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
[TBL] [Abstract][Full Text] [Related]
24. Respiratory illness associated with influenza and respiratory syncytial virus infection.
Fleming DM; Pannell RS; Elliot AJ; Cross KW
Arch Dis Child; 2005 Jul; 90(7):741-6. PubMed ID: 15855178
[TBL] [Abstract][Full Text] [Related]
25. Passive smoking after tympanostomy and risk of recurrent acute otitis media.
Hammarén-Malmi S; Saxen H; Tarkkanen J; Mattila PS
Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1305-10. PubMed ID: 17582514
[TBL] [Abstract][Full Text] [Related]
26. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
27. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
[TBL] [Abstract][Full Text] [Related]
29. Age-related difference in immune responses to respiratory syncytial virus infection in young children.
Chung HL; Park HJ; Kim SY; Kim SG
Pediatr Allergy Immunol; 2007 Mar; 18(2):94-9. PubMed ID: 17338780
[TBL] [Abstract][Full Text] [Related]
30. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic use in children is not influenced by the result of rapid antigen detection test for the respiratory syncytial virus.
Thibeault R; Gilca R; Côté S; De Serres G; Boivin G; Déry P
J Clin Virol; 2007 Jul; 39(3):169-74. PubMed ID: 17532258
[TBL] [Abstract][Full Text] [Related]
32. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children].
Bergsträsser E; Zbinden R; Minder C; Gnehm HE
Klin Padiatr; 1998; 210(6):418-21. PubMed ID: 9871899
[TBL] [Abstract][Full Text] [Related]
33. [The correlation factor about respiratory syncytial virus bronchiolitis and post-bronchiolitis wheezing in infant].
Tian M; Zhao DY; Wen GY; Shi SY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):371-4. PubMed ID: 20387490
[TBL] [Abstract][Full Text] [Related]
34. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response.
Kristjansson S; Bjarnarson SP; Wennergren G; Palsdottir AH; Arnadottir T; Haraldsson A; Jonsdottir I
J Allergy Clin Immunol; 2005 Oct; 116(4):805-11. PubMed ID: 16210054
[TBL] [Abstract][Full Text] [Related]
35. Passive smoking and nonrecurrent acute otitis media in children.
Lubianca Neto JF; Burns AG; Lu L; Mombach R; Saffer M
Otolaryngol Head Neck Surg; 1999 Dec; 121(6):805-8. PubMed ID: 10580242
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of respiratory syncytial virus infection-associated acute otitis media.
Tomochika K; Ichiyama T; Shimogori H; Sugahara K; Yamashita H; Furukawa S
Pediatr Int; 2009 Aug; 51(4):484-7. PubMed ID: 19674360
[TBL] [Abstract][Full Text] [Related]
37. Respiratory Syncytial Virus-associated Acute Otitis Media in Infants and Children.
Phillips M; Finelli L; Saiman L; Wang C; Choi Y; Patel J
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):544-550. PubMed ID: 32886769
[TBL] [Abstract][Full Text] [Related]
38. Study of Effect of Household Parental Smoking on Development of Acute Otitis Media in Children Under 12 Years.
Amani S; Yarmohammadi P
Glob J Health Sci; 2015 Sep; 8(5):81-8. PubMed ID: 26652088
[TBL] [Abstract][Full Text] [Related]
39. Incidence of acute otitis media associated with group A and B respiratory syncytial virus infections.
Heikkinen T; Waris M; Ruuskanen O; Putto-Laurila A; Mertsola J
Acta Paediatr; 1995 Apr; 84(4):419-23. PubMed ID: 7795353
[TBL] [Abstract][Full Text] [Related]
40. Risk of acute otitis media in relation to the viral etiology of infections in children.
Uhari M; Hietala J; Tuokko H
Clin Infect Dis; 1995 Mar; 20(3):521-4. PubMed ID: 7756470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
